CCL2 and COVID-19: As depicted in Figure 3, cytokines such as TNF- α, CCL2, CXCL8, and IL6, which show high levels in COVID-19 patients requiring ICU admission (Li et al., 2020), can predictably be inhibited by the bioactive components.